Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report.

Kuruc JC, Durant-Archibold AA, Motta J, Rao KS, Trachtenberg B, Ramos C, Wang H, Gorenstein D, Vannberg F, Jordan K.

BMC Cardiovasc Disord. 2019 Jul 16;19(1):169. doi: 10.1186/s12872-019-1155-7.

2.

Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.

Huang C, Clayton EA, Matyunina LV, McDonald LD, Benigno BB, Vannberg F, McDonald JF.

Sci Rep. 2018 Nov 6;8(1):16444. doi: 10.1038/s41598-018-34753-5.

3.

Ribose-Map: a bioinformatics toolkit to map ribonucleotides embedded in genomic DNA.

Gombolay AL, Vannberg FO, Storici F.

Nucleic Acids Res. 2019 Jan 10;47(1):e5. doi: 10.1093/nar/gky874.

4.

Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.

Talundzic E, Ravishankar S, Kelley J, Patel D, Plucinski M, Schmedes S, Ljolje D, Clemons B, Madison-Antenucci S, Arguin PM, Lucchi NW, Vannberg F, Udhayakumar V.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02474-17. doi: 10.1128/AAC.02474-17. Print 2018 Apr.

5.

Mapping-free variant calling using haplotype reconstruction from k-mer frequencies.

Audano PA, Ravishankar S, Vannberg FO.

Bioinformatics. 2018 May 15;34(10):1659-1665. doi: 10.1093/bioinformatics/btx753.

6.

Open source machine-learning algorithms for the prediction of optimal cancer drug therapies.

Huang C, Mezencev R, McDonald JF, Vannberg F.

PLoS One. 2017 Oct 26;12(10):e0186906. doi: 10.1371/journal.pone.0186906. eCollection 2017.

7.

TLR-exosomes exhibit distinct kinetics and effector function.

Srinivasan S, Su M, Ravishankar S, Moore J, Head P, Dixon JB, Vannberg F.

Sci Rep. 2017 Mar 14;7:41623. doi: 10.1038/srep41623.

8.

First Full Draft Genome Sequence of Plasmodium brasilianum.

Talundzic E, Ravishankar S, Nayak V, Patel DS, Olsen C, Sheth M, Batra D, Loparev V, Vannberg FO, Udhayakumar V, Barnwell JW.

Genome Announc. 2017 Feb 9;5(6). pii: e01566-16. doi: 10.1128/genomeA.01566-16.

9.

Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.

Talundzic E, Ndiaye YD, Deme AB, Olsen C, Patel DS, Biliya S, Daniels R, Vannberg FO, Volkman SK, Udhayakumar V, Ndiaye D.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02116-16. doi: 10.1128/AAC.02116-16. Print 2017 Mar.

10.

Chocó, Colombia: a hotspot of human biodiversity.

Medina-Rivas MA, Norris ET, Rishishwar L, Conley AB, Medrano-Trochez C, Valderrama-Aguirre A, Vannberg FO, Mariño-Ramírez L, Jordan IK.

Rev Biodivers Neotrop. 2016 Jan-Jun;6(1):45-54.

11.

Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node.

Srinivasan S, Vannberg FO, Dixon JB.

Sci Rep. 2016 Apr 18;6:24436. doi: 10.1038/srep24436.

12.

Advanced Molecular Detection of Malarone Resistance.

Talundzic E, Plucinski MM, Biliya S, Silva-Flannery LM, Arguin PM, Halsey ES, Barnwell JW, Vannberg F, Udhayakumar V.

Antimicrob Agents Chemother. 2016 May 23;60(6):3821-3. doi: 10.1128/AAC.00171-16. Print 2016 Jun.

13.

Ligation of RNA Oligomers by the Schistosoma mansoni Hammerhead Ribozyme in Frozen Solution.

Lie L, Biliya S, Vannberg F, Wartell RM.

J Mol Evol. 2016 Mar;82(2-3):81-92. doi: 10.1007/s00239-016-9729-9. Epub 2016 Feb 20.

PMID:
26897022
14.

Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections.

Etienne KA, Roe CC, Smith RM, Vallabhaneni S, Duarte C, Escadon P, Castaneda E, Gomez BL, de Bedout C, López LF, Salas V, Hederra LM, Fernandez J, Pidal P, Hormazabel JC, Otaiza F, Vannberg FO, Gillece J, Lemmer D, Driebe EM, Englethaler DM, Litvintseva AP.

Emerg Infect Dis. 2016 Mar;22(3):476-81. doi: 10.3201/eid2203.151193.

15.

KAnalyze: a fast versatile pipelined k-mer toolkit.

Audano P, Vannberg F.

Bioinformatics. 2014 Jul 15;30(14):2070-2. doi: 10.1093/bioinformatics/btu152. Epub 2014 Mar 18.

16.

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, Rucart P, Sandhu MS, Shea PR, Schuitemaker H, Theodorou I, Vannberg F, Veldink J, Walker BD, Weintrob A, Winkler CA, Wolinsky S, Telenti A, Goldstein DB, de Bakker PI, Zagury JF, Fellay J.

PLoS Pathog. 2013;9(7):e1003515. doi: 10.1371/journal.ppat.1003515. Epub 2013 Jul 25.

17.

Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population.

Bowdish DM, Sakamoto K, Lack NA, Hill PC, Sirugo G, Newport MJ, Gordon S, Hill AV, Vannberg FO.

BMC Med Genet. 2013 Apr 23;14:47. doi: 10.1186/1471-2350-14-47.

18.

Identifying recent adaptations in large-scale genomic data.

Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, Park DJ, Griesemer D, Karlsson EK, Wong SH, Cabili M, Adegbola RA, Bamezai RN, Hill AV, Vannberg FO, Rinn JL; 1000 Genomes Project, Lander ES, Schaffner SF, Sabeti PC.

Cell. 2013 Feb 14;152(4):703-13. doi: 10.1016/j.cell.2013.01.035.

19.

Effect of HIV-2 infection on HIV-1 disease progression.

Vannberg FO, McDermid JM, Jaye A; MRC Gambia HIV Clinical Cohort Study; Wellcome Trust Case Control Consortium 3.

N Engl J Med. 2012 Nov 15;367(20):1962; author reply 1962-3. doi: 10.1056/NEJMc1210334. No abstract available.

PMID:
23150975
20.

PTX3 genetic variation and dizygotic twinning in the Gambia: could pleiotropy with innate immunity explain common dizygotic twinning in Africa?

Sirugo G, Edwards DR, Ryckman KK, Bisseye C, White MJ, Kebbeh B, Morris GA, Adegbola RA, Tacconelli A, Predazzi IM, Novelli G, Vannberg FO, Odunsi K, Page GP, Williams SM.

Ann Hum Genet. 2012 Nov;76(6):454-63. doi: 10.1111/j.1469-1809.2012.00723.x. Epub 2012 Jul 27.

21.

Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.

Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, Dilthey A, Ellis P, Langford C, Vannberg FO, Knight JC.

Nat Genet. 2012 Mar 25;44(5):502-10. doi: 10.1038/ng.2205.

22.

Common variants at 11p13 are associated with susceptibility to tuberculosis.

Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E, Balabanova Y, Ehmen C, Muntau B, Ruge G, Sievertsen J, Gyapong J, Nikolayevskyy V, Hill PC, Sirugo G, Drobniewski F, van de Vosse E, Newport M, Alisjahbana B, Nejentsev S, Ottenhoff TH, Hill AV, Horstmann RD, Meyer CG.

Nat Genet. 2012 Feb 5;44(3):257-9. doi: 10.1038/ng.1080.

23.

Human genetic susceptibility to intracellular pathogens.

Vannberg FO, Chapman SJ, Hill AV.

Immunol Rev. 2011 Mar;240(1):105-16. doi: 10.1111/j.1600-065X.2010.00996.x. Review.

PMID:
21349089
24.

A common haplotype of the TNF receptor 2 gene modulates endotoxin tolerance.

Fairfax BP, Davenport EE, Makino S, Hill AV, Vannberg FO, Knight JC.

J Immunol. 2011 Mar 1;186(5):3058-65. doi: 10.4049/jimmunol.1001791. Epub 2011 Jan 31.

25.

Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study.

Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Walley A, Segal S, Moore CE, Davies RJ, Day NP, Peshu N, Crook DW, Berkley JA, Williams TN, Scott JA, Hill AV.

Crit Care. 2010;14(6):R227. doi: 10.1186/cc9377. Epub 2010 Dec 20.

26.

A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

Kubarenko AV, Ranjan S, Rautanen A, Mills TC, Wong S, Vannberg F, Neumaier M, Bekeredjian-Ding I, Hill AV, Ahmad-Nejad P, Weber AN.

J Biol Chem. 2010 Nov 19;285(47):36486-94. doi: 10.1074/jbc.M110.117200. Epub 2010 Sep 14.

27.

Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2.

Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, Sirugo G, Sisay-Joof F, Enimil A, Chinbuah MA, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Ngwira B, Teo YY, Small K, Rockett K, Kwiatkowski D, Fine PE, Hill PC, Newport M, Lienhardt C, Adegbola RA, Corrah T, Ziegler A; African TB Genetics Consortium; Wellcome Trust Case Control Consortium, Morris AP, Meyer CG, Horstmann RD, Hill AVS.

Nat Genet. 2010 Sep;42(9):739-741. doi: 10.1038/ng.639. Epub 2010 Aug 8. Erratum in: Nat Genet. 2011 Oct;43(10):1040.

28.

Leprosy and the adaptation of human toll-like receptor 1.

Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, Khor CC, Rautanen A, Chapman SJ, Mills TC, Srivastava A, Rudko A, Freidin MB, Puzyrev VP, Ali S, Aggarwal S, Chopra R, Reddy BS, Garg VK, Roy S, Meisner S, Hazra SK, Saha B, Floyd S, Keating BJ, Kim C, Fairfax BP, Knight JC, Hill PC, Adegbola RA, Hakonarson H, Fine PE, Pitchappan RM, Bamezai RN, Hill AV, Vannberg FO.

PLoS Pathog. 2010 Jul 1;6:e1000979. doi: 10.1371/journal.ppat.1000979.

29.

CISH and susceptibility to infectious diseases.

Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, Vukcevic D, Rautanen A, Mills TC, Chang KC, Kam KM, Crampin AC, Ngwira B, Leung CC, Tam CM, Chan CY, Sung JJ, Yew WW, Toh KY, Tay SK, Kwiatkowski D, Lienhardt C, Hien TT, Day NP, Peshu N, Marsh K, Maitland K, Scott JA, Williams TN, Berkley JA, Floyd S, Tang NL, Fine PE, Goh DL, Hill AV.

N Engl J Med. 2010 Jun 3;362(22):2092-101. doi: 10.1056/NEJMoa0905606. Epub 2010 May 19.

30.

Genomewide association study of leprosy.

Wong SH, Hill AV, Vannberg FO; India-Africa-United Kingdom Leprosy Genetics Consortium.

N Engl J Med. 2010 Apr 15;362(15):1446-7; author reply 1447-8. doi: 10.1056/NEJMc1001451. No abstract available.

PMID:
20393182
31.

Comment on "CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node".

Wong SH, Vannberg FO, Spencer AJ, van der Weyden L, Hill AV, Wyllie DH.

J Immunol. 2010 Apr 15;184(8):4052-3. doi: 10.4049/jimmunol.1090017. No abstract available.

32.

Mannose-binding lectin genotypes: lack of association with susceptibility to thoracic empyema.

Chapman SJ, Vannberg FO, Khor CC, Rautanen A, Maskell NA, Davies CW, Moore CE, Day NP, Crook DW, Davies RJ, Hill AV.

BMC Med Genet. 2010 Jan 15;11:5. doi: 10.1186/1471-2350-11-5.

33.

An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6.

Fairfax BP, Vannberg FO, Radhakrishnan J, Hakonarson H, Keating BJ, Hill AV, Knight JC.

Hum Mol Genet. 2010 Feb 15;19(4):720-30. doi: 10.1093/hmg/ddp530. Epub 2009 Nov 26.

34.

NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations.

Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Segal S, Moore CE, Davies RJ, Day NP, Peshu N, Crook DW, Berkley JA, Williams TN, Scott JA, Hill AV.

Genes Immun. 2010 Jun;11(4):319-25. doi: 10.1038/gene.2009.76. Epub 2009 Oct 1.

35.

CD209 genetic polymorphism and tuberculosis disease.

Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, Jackson-Sillah D, Crampin A, Sichali L, Bah B, Gustafson P, Aaby P, McAdam KP, Bah-Sow O, Lienhardt C, Sirugo G, Fine P, Hill AV.

PLoS One. 2008 Jan 2;3(1):e1388. doi: 10.1371/journal.pone.0001388.

36.

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.

Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskivina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop TD, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Matthew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop MG, Connell J, Dominiczak A, Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfield M, Farrall M, Barton A; Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hilder SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DP, Thomson W, Worthington J, Dunger DB, Widmer B, Frayling TM, Freathy RM, Lango H, Perry JR, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, Newport M, Sirugo G, Lyons E, Vannberg F, Hill AV, Bradbury LA, Farrar C, Pointon JJ, Wordsworth P, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Gough SC, Seal S; Breast Cancer Susceptibility Collaboration (UK), Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Newport M, Sirugo G, Rockett KA, Bumpstead SJ, Chaney A, Downes K, Ghori MJ, Gwilliam R, Hunt SE, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Widden C, Withers D, Cardin NJ, Davison D, Ferreira T, Pereira-Gale J, Hallgrimsdo'ttir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Brown MA, Compston A, Farrall M, Hall AS, Hattersley AT, Hill AV, Parkes M, Pembrey M, Stratton MR, Mitchell SL, Newby PR, Brand OJ, Carr-Smith J, Pearce SH, McGinnis R, Keniry A, Deloukas P, Reveille JD, Zhou X, Sims AM, Dowling A, Taylor J, Doan T, Davis JC, Savage L, Ward MM, Learch TL, Weisman MH, Brown M.

Nat Genet. 2007 Nov;39(11):1329-37. Epub 2007 Oct 21.

37.

Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.

Khor CC, Vannberg FO, Chapman SJ, Walley A, Aucan C, Loke H, White NJ, Peto T, Khor LK, Kwiatkowski D, Day N, Scott A, Berkley JA, Marsh K, Peshu N, Maitland K, Williams TN, Hill AV.

Genes Immun. 2007 Oct;8(7):570-6. Epub 2007 Aug 16.

38.

IkappaB genetic polymorphisms and invasive pneumococcal disease.

Chapman SJ, Khor CC, Vannberg FO, Frodsham A, Walley A, Maskell NA, Davies CW, Segal S, Moore CE, Gillespie SH, Denny P, Day NP, Crook DW, Davies RJ, Hill AV.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):181-7. Epub 2007 Apr 26.

PMID:
17463416
39.

Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease.

Chapman SJ, Vannberg FO, Khor CC, Segal S, Moore CE, Knox K, Day NP, Davies RJ, Crook DW, Hill AV.

Mol Immunol. 2007 May;44(12):3267-70. Epub 2007 Mar 26.

PMID:
17382393
40.

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.

Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV.

Nat Genet. 2007 Apr;39(4):523-8. Epub 2007 Feb 25.

41.

PTPN22 and invasive bacterial disease.

Chapman SJ, Khor CC, Vannberg FO, Maskell NA, Davies CW, Hedley EL, Segal S, Moore CE, Knox K, Day NP, Gillespie SH, Crook DW, Davies RJ, Hill AV.

Nat Genet. 2006 May;38(5):499-500. No abstract available.

PMID:
16642008
42.

Building a human kinase gene repository: bioinformatics, molecular cloning, and functional validation.

Park J, Hu Y, Murthy TV, Vannberg F, Shen B, Rolfs A, Hutti JE, Cantley LC, Labaer J, Harlow E, Brizuela L.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8114-9. Epub 2005 May 31.

43.

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, Ndung'u T, Klein I, Chang SY, Peter T, Thior I, Foley BT, Gaolekwe S, Rybak N, Gaseitsiwe S, Vannberg F, Marlink R, Lee TH, Essex M.

J Virol. 2002 Jun;76(11):5435-51.

44.

Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I, Gaolekwe S, Chang SY, Peter T, Thior I, Ndung'u T, Vannberg F, Foley BT, Marlink R, Lee TH, Essex M.

J Virol. 2001 Oct;75(19):9210-28.

45.

The molecular epidemiology of HIV type 1 of men in Mexico.

Rivera-Morales LG, Novitsky VA, Trujillo JR, Lavalle-Montalvo C, Cano-Dominguez C, Ramos-Jimenez J, Jimenez-Rios E, Flores-Flores L, Lopez-Guillen P, Gilbert P, Vannberg F, Tamez-Guerra R, Rodriguez-Padilla C, Essex M.

AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):87-92.

PMID:
11177387
46.

HIV type 1 A/J recombinant with a pronounced pol gene mosaicism.

Novitsky VA, Gaolekwe S, McLane MF, Ndung'u TP, Foley BT, Vannberg F, Marlink R, Essex M.

AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):1015-20.

PMID:
10890363
47.

Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region.

Renjifo B, Gilbert P, Chaplin B, Vannberg F, Mwakagile D, Msamanga G, Hunter D, Fawzi W, Essex M.

AIDS. 1999 Sep 10;13(13):1613-21.

PMID:
10509561
48.

Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhema MJ, Marlink R, Essex M.

J Virol. 1999 May;73(5):4427-32.

49.

Identification of genes differentially expressed in Mycobacterium tuberculosis by differential display PCR.

Rivera-Marrero CA, Burroughs MA, Masse RA, Vannberg FO, Leimbach DL, Roman J, Murtagh JJ Jr.

Microb Pathog. 1998 Dec;25(6):307-16.

PMID:
9895269
50.

Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania.

Renjifo B, Chaplin B, Mwakagile D, Shah P, Vannberg F, Msamanga G, Hunter D, Fawzi W, Essex M.

AIDS Res Hum Retroviruses. 1998 May 1;14(7):635-8. No abstract available.

PMID:
9591718

Supplemental Content

Loading ...
Support Center